From October 1, 2021 to December 31, 2021, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 2,216,600 shares, representing 0.16% for CNY 40.01 million under the buyback announced on July 30, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.52 CNY | -1.90% |
|
+0.63% | +5.06% |
07-02 | Kelun-Biotech to Buy Equipment from Affiliate | MT |
07-02 | Kelun-Biotech to Buy Equipment from Sichuan Kelun Pharmaceutical's Unit | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.06% | 6.81B | |
+57.66% | 823B | |
-6.87% | 353B | |
+15.49% | 320B | |
+7.66% | 295B | |
+13.62% | 239B | |
+14.55% | 220B | |
-0.33% | 219B | |
+8.30% | 167B | |
-2.94% | 159B |
- Stock Market
- Equities
- 002422 Stock
- News Sichuan Kelun Pharmaceutical Co., Ltd.
- Tranche Update on Sichuan Kelun Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 30, 2021.